701.8000 21.45 (3.15%)
NSE Jun 27, 2025 15:31 PM
Volume: 3.2M
 

701.80
3.15%
Motilal Oswal
Laurus Lab (LAURUS) significantly beat our earnings estimates in 3QFY25, led by a scale-up in the CDMO segment. Commercial supplies (including launch quantities) led to strong 89% YoY growth in CDMO sales for the quarter.
Number of FII/FPI investors increased from 237 to 259 in Mar 2025 qtr.
More from Laurus Labs Ltd.
All Rapid Results
Recommended